Autres langues Jointown Pharmaceutical Group Co., Ltd

Actions

600998

CNE100000W45

Produits pharmaceutiques

Cours en clôture Shanghai S.E. 31/08/2026			Varia. 5j.	Varia. 1 janv.
4,840 ^CNY	-1,22%		-1,43%	-5,47%

24/08	Jointown Pharmaceutical Group Co., Ltd publie ses résultats pour le semestre clos le 30 juin 2026	CI
24/08	Jointown Pharmaceutical s'associe à National Pension Insurance dans les services aux seniors	MT

Autres langues

24/08	Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026
24/08	Jointown Pharmaceutical to Partner with National Pension Insurance for Elderly Services
29/07	Jointown Pharmaceutical Plans Up to 2.2-Billion-Yuan Factoring
16/07	Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List
11/06	Jointown Pharma Issues 1 Billion Yuan in Asset-Backed Securities
03/06	Jointown Pharmaceutical Unit Gets Nod to Market Allergy Symptoms Treatment
27/05	Jointown Pharma Unit Passes China Generic Drug Evaluation
07/05	Jointown Pharmaceutical Unit Passes Shandong GMP Inspection
27/04	Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026
27/04	Jointown Pharmaceutical says Q1 net profit down 24.4% Y/Y
27/04	Jointown Pharmaceutical Group Co., Ltd announces Annual dividend, payable on June 08, 2026
22/04	Ruijiming Biotechnology Co., Ltd. announced that it has received CNY 17 million in funding from Jointown Pharmaceutical Group Co., Ltd
07/01	Jointown Subsidiary Gets China Approval for Anesthetic
30/12	Jointown Pharmaceutical Gets Completion Ruling for Subsidiary's Reorganization
29/12	Jointown Pharmaceutical Unit Gets Drug Registration for Antihistamine Drug
22/12	Jointown Pharmaceutical Group Expects Up to 2.1 Billion Yuan in 2026 Related-Party Transactions
18/12	Jointown Pharmaceutical Discloses Potential Shareholding Change
24/11	Jointown Pharmaceutical Issues 1 Billion Yuan Asset-Backed Bonds
14/11	Jointown Pharmaceutical Shareholder Pledges 166 Million Shares
12/11	Jointown Pharmaceutical Unit's Industrial Investment Fund Completes Registration
28/10/25	Jointown Pharmaceutical's Q3 Profit Rises 9%, Revenue Increases 5%
27/10/25	Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025
27/10/25	Jointown Pharmaceutical Q3 net profit up 8.5% Y/Y
17/10/25	Jointown Pharmaceutical's Unit Gets Nod to Market Glycopyrronium Bromide API
23/09/25	Jointown Pharmaceutical's Unit to Invest 10 Million Yuan Into Healthcare Partnership Fund; Shares Down 3%